David R. Byrd

26.8k citations
176 papers · 20.6k · 5 hit papers · h-index 51

Impact in

  • Oncology top 0.1%
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
    • Polyomavirus and related diseases
    • Cancer Immunotherapy and Biomarkers
    • Breast Cancer Treatment Studies

Papers in

    • Pancreatic and Hepatic Oncology Research 15
    • Cutaneous Melanoma Detection and Management 14
    • Polyomavirus and related diseases 11
    • Breast Cancer Treatment Studies 10
    • Cancer Genomics and Diagnostics 9

David R. Byrd

168 papers receiving 20.0k citations

David R. Byrd's Hit Papers

Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal 2020 · 424 citations
4240+8+16Years since publication10002.0k3.0k4.0k

Peers

David R. Byrd
Comparison fields: 5 of 179
  • Oncology 11.2k
  • Cancer Research 2.2k
  • Otorhinolaryngology 522
  • Immunology 2.0k
  • Dermatology 829
Replace Gerardo Botti with:
Gerardo Botti Italy
Vera Jean Suman United States
Richard S. Kaplan United Kingdom
Bita Esmaeli United States
Stephen B. Fox Australia
Janet Ellen Dancey United States
Paul J van Diest Netherlands
Albrecht Stenzinger Germany
Taofeek Kunle Owonikoko United States
Andre Luis Moreira United States
David R. Byrd relative to Gerardo Botti Italy Gerardo Botti's profile →
Citations per field
00.5×2×3.1×
Gerardo Botti · 1×
Citations per year

Countries citing papers authored by David R. Byrd

Since Specialization
Citations

This map shows the geographic impact of David R. Byrd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Byrd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Byrd more than expected).

Fields of papers citing papers by David R. Byrd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Byrd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Byrd. The network helps show where David R. Byrd may publish in the future.

Co-authors

The 25 scholars most cited alongside David R. Byrd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David R. Byrd Line = papers co-authored together David R. Byrd links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging
Hit paper breakdown →
20174956
2
Final Version of 2009 AJCC Melanoma Staging and Classification
Hit paper breakdown →
20093801
3
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
Hit paper breakdown →
20011977
4
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Hit paper breakdown →
20171011
5 2010434
6
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
Hit paper breakdown →
2020424
7 2000370
8 1999334
9 2010331
10 2011294
11 2018268
12 1998258
13 2011252
14 2000236
15 1995217
16 2017213
17 2012208
18 2011185
19 2016184
20 2010180

About David R. Byrd

David R. Byrd is a scholar working on Oncology, Cancer Research, Surgery, Pathology and Forensic Medicine and Language and Linguistics, having authored 176 papers that have together received 20.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (15 papers), Cutaneous Melanoma Detection and Management (14 papers), Polyomavirus and related diseases (11 papers), EFL/ESL Teaching and Learning (10 papers), Breast Cancer Treatment Studies (10 papers), Cancer Genomics and Diagnostics (9 papers), Thyroid Cancer Diagnosis and Treatment (8 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Oncology (11.2k citations), Cancer Research (2.2k citations), Otorhinolaryngology (522 citations), Immunology (2.0k citations) and Dermatology (829 citations). David R. Byrd has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Carolyn C. Compton, Donna M. Gress, David Porter Winchester, Laura Meyer, Stephen B. Edge, Mahul B. Amin, Frederick L. Greene, Robert K. Brookland, Merrick I. Ross and Jeffrey E. Gershenwald. Their work appears in journals such as Journal of the National Comprehensive Cancer Network, Journal of the American Academy of Dermatology, Journal of Clinical Oncology, Annals of Surgical Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact